methotrexate has been researched along with Lacrimal Duct Obstruction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burakgazi-Dalkilic, E; Esmer, O; Karadag, R; Oner, AF; Soylu, E | 1 |
| Spooner, D; Stevens, A | 1 |
1 review(s) available for methotrexate and Lacrimal Duct Obstruction
| Article | Year |
|---|---|
Lacrimal duct stenosis and other ocular toxicity associated with adjuvant cyclophosphamide, methotrexate and 5-fluorouracil combination chemotherapy for early stage breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Humans; Lacrimal Duct Obstruction; Methotrexate; Middle Aged; Neoplasm Staging; Postmenopause; Retrospective Studies | 2001 |
1 other study(ies) available for methotrexate and Lacrimal Duct Obstruction
| Article | Year |
|---|---|
Nasolacrimal system obstruction, ptosis and esotropia due to chemotherapy in acute lymphoblastic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blepharoptosis; Child; Daunorubicin; Esotropia; Female; Humans; Lacrimal Duct Obstruction; Methotrexate; Nasolacrimal Duct; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Vincristine | 2013 |